EUCRU

Eucrates Biomedical Acquisition Corp. Unit
EUCRU

Delisted

EUCRU was delisted on the 26th of April, 2023.

Back to rankings

19 hedge funds and large institutions have $38.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$114K
2
+$47

Top Sellers

1
-$4M
2
-$2.01M
3
-$1.02M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$571K
5
MS
Maven Securities
Jersey
-$331K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$10.2M
2
$7.45M
3
$5.09M
4
$4.05M
5
$3.06M
6
$2.39M
7
$2.1M
8
$1.19M
9
$979K
10
$816K
11
$814K
12
$435K
13
$116K
14
$114K
15
$27K
16
$14K
17
$4.63K
18
$1K
19
–
20
–
21
–
22
–
23
–